Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

COG, Apeiron Join for Neuroblastoma Study

September 29, 2011 12:35 pm | News | Comments

Children´s Oncology Group (COG) and Apeiron Biologics AG will jointly investigate Apeiron´s APN301 in a clinical Phase 2 study in pediatric neuroblastoma patients.

TOPICS:

Cat Cancer Risk Factors May Help Humans

September 29, 2011 12:30 pm | News | Comments

A large-scale study on cat intestinal cancer has provided insight into a common pet disease and its causes, a finding that could ultimately benefit humans.

TOPICS:

Lodotra Gains New Drug Application Submission

September 29, 2011 12:23 pm | News | Comments

SkyePharma PLC announced that its licensee, Horizon Pharma, Inc. submitted a New Drug Application to the United States Food and Drug Administration for Lodotra for the treatment of active rheumatoid arthritis.

TOPICS:
Advertisement

From a Healthy Cell to a Tumor

September 29, 2011 12:17 pm | News | Comments

Brain tumor specimens taken from neurosurgery cases at the University of California, San Francisco (UCSF) Medical Center have given scientists a new window on the transformation that occurs as healthy brain cells begin to form tumors.

TOPICS:

Web-Based Document Manager

September 29, 2011 12:06 pm | Product Releases | Comments

BBK Worldwide’s DocManager v2 facilitates optimal workflow within a closed and secure web-based environment and ensures that documents are organized for various levels of review to avoid common pitfalls that delay project implementations.

TOPICS:

Radiography Film

September 29, 2011 8:11 am | Product Releases | Comments

GE Healthcare Life Sciences has extended its range of Amersham Hyperfilm products with Amersham Hyperfilm Blue, a blue sensitive film which enables rapid, qualitative results for the detection of chemiluminescent signals in different blotting assays.

TOPICS:

Automated Cell Culturing

September 29, 2011 8:07 am | Product Releases | Comments

The Automation Partnership's CompacT SelecT system for automated culturing of cell lines in T-flasks, is now available with an integrated Beckman Coulter Vi-CELL XR Cell Viability Analyser.

TOPICS:

Millipore Launches Recycling Program

September 29, 2011 7:54 am | News | Comments

EMD Millipore has launched ech2o, a collection and recycling program for EMD Millipore laboratory water purification consumables. The program allows users to return exhausted cartridges for dismantling.

TOPICS:
Advertisement

Pharma's Loss is Supermarket's Gain

September 29, 2011 7:47 am | News | Comments

Moody's Investors Service said that supermarkets with big pharmacy sections will get a boost to their profits in 2012 as low-cost versions of some of the world's best-selling pharmaceuticals reach the market.

TOPICS:

OTO-104 Reduces Vertigo in New Trial

September 29, 2011 7:42 am | News | Comments

Otonomy, Inc. researchers presented positive new data from a Phase 1b study of the company’s lead product candidate, OTO-104, in patients with Ménière’s disease.

TOPICS:

Pfizer Warning About Counterfeit Meds

September 29, 2011 7:39 am | by Linda A. Johnson | News | Comments

Pfizer Inc. and a pharmacy standards group are teaming to warn U.S. consumers about the risks of counterfeit prescription medicines, which endanger the public and take money from both pharmacies and legitimate drugmakers.

TOPICS:

Abbott Spends $500K Lobbying Government

September 29, 2011 7:37 am | News | Comments

Drug and medical device maker Abbott Laboratories spent a half-million dollars in the second quarter to lobby the federal government on policies affecting its various products, which range from biotech drugs to infant formulas.

TOPICS:

Soviet-Era Pill Helps Smokers Quit

September 29, 2011 7:34 am | by Maria Cheng | News | Comments

A pill developed in Bulgaria during the Soviet era shows promise for helping millions of smokers cheaply and safely kick the habit, the first big study of it shows.

TOPICS:

Merck Sells Its Half of Joint Venture

September 29, 2011 7:30 am | News | Comments

Drugmaker Merck & Co. has sold its interest in a 22-year-old joint venture that makes and sells over-the-counter drugs to Johnson & Johnson for $175 million.

TOPICS:

FDA Warns About Blood Clots From Drospirenone

September 28, 2011 12:26 pm | News | Comments

While the U.S. Food and Drug Administration has not reached a conclusion on the risk for blood clots in women using drospirenone-containing birth control pills, the agency released an updated safety announcement regarding its concerns about the potential increased risk.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading